Literature DB >> 22013224

IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association.

Fatma M Shebl1, Ruth M Pfeiffer, Dianna Buckett, Brian Muchmore, Sabrina Chen, Myhanh Dotrang, Ludmila Prokunina-Olsson, Brian R Edlin, Thomas R O'Brien.   

Abstract

Among 1369 Urban Health Study participants, we evaluated genetic models for the association of IL28B genotype (rs12979860 and rs8099917) with hepatitis C virus (HCV) clearance. For rs12979860, adjusted odds ratios for spontaneous HCV clearance were as follows: IL28B-CC, 3.88 (P < .001); IL28B-CT, 1.48 (P = .08). On the basis of Akaike information criteria values and χ(2) tests, a supra-additive (quadratic) model fit these data best. Models based on rs8099917 provided poorer fit. Evidence that a supra-additive rs12979860-based model best fits the association of IL28B-genotype with HCV clearance may improve clinical prediction models and foster a better understanding of functional mechanisms underlying this association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013224      PMCID: PMC3209810          DOI: 10.1093/infdis/jir647

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Genetic association studies: design, analysis and interpretation.

Authors:  Cathryn M Lewis
Journal:  Brief Bioinform       Date:  2002-06       Impact factor: 11.622

Review 2.  Choosing among generalized linear models applied to medical data.

Authors:  J K Lindsey; B Jones
Journal:  Stat Med       Date:  1998-01-15       Impact factor: 2.373

3.  An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.

Authors:  Alessandra Mangia; Alexander J Thompson; Rosanna Santoro; Valeria Piazzolla; Hans L Tillmann; Keyur Patel; Kevin V Shianna; Leonardo Mottola; Daniela Petruzzellis; Donato Bacca; Vito Carretta; Nicola Minerva; David B Goldstein; John G McHutchison
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

4.  Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.

Authors:  Alexander J Thompson; Andrew J Muir; Mark S Sulkowski; Dongliang Ge; Jacques Fellay; Kevin V Shianna; Thomas Urban; Nezam H Afdhal; Ira M Jacobson; Rafael Esteban; Fred Poordad; Eric J Lawitz; Jonathan McCone; Mitchell L Shiffman; Greg W Galler; William M Lee; Robert Reindollar; John W King; Paul Y Kwo; Reem H Ghalib; Bradley Freilich; Lisa M Nyberg; Stefan Zeuzem; Thierry Poynard; David M Vock; Karen S Pieper; Keyur Patel; Hans L Tillmann; Stephanie Noviello; Kenneth Koury; Lisa D Pedicone; Clifford A Brass; Janice K Albrecht; David B Goldstein; John G McHutchison
Journal:  Gastroenterology       Date:  2010-04-24       Impact factor: 22.682

5.  HIV seroprevalence in injection drug users.

Authors:  J K Watters; R N Bluthenthal; A H Kral
Journal:  JAMA       Date:  1995-04-19       Impact factor: 56.272

6.  A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Authors:  Hans L Tillmann; Alex J Thompson; Keyur Patel; Manfred Wiese; Hannelore Tenckhoff; Hans D Nischalke; Yuliya Lokhnygina; Ulrike Kullig; Uwe Göbel; Emanuela Capka; Johannes Wiegand; Ingolf Schiefke; Wolfgang Güthoff; Kurt Grüngreiff; Ingrid König; Ulrich Spengler; Jeanette McCarthy; Kevin V Shianna; David B Goldstein; John G McHutchison; Jörg Timm; Jacob Nattermann
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

Review 7.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

8.  An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.

Authors:  Thomas R O'Brien; James E Everhart; Timothy R Morgan; Anna S Lok; Raymond T Chung; Yongwu Shao; Mitchell L Shiffman; Myhanh Dotrang; John J Sninsky; Herbert L Bonkovsky; Ruth M Pfeiffer
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

9.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

10.  MBL2 and hepatitis C virus infection among injection drug users.

Authors:  Elizabeth E Brown; Mingdong Zhang; Rebecca Zarin-Pass; Toralf Bernig; Fan-Chen Tseng; Nianqing Xiao; Meredith Yeager; Brian R Edlin; Stephen J Chanock; Thomas R O'Brien
Journal:  BMC Infect Dis       Date:  2008-05-01       Impact factor: 3.090

View more
  12 in total

1.  Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.

Authors:  Lilliana Morales-Vásquez; Edgar I Miranda-Avalo; José R Rodríguez-Medina; Yomarid Quiñones-Badillo; Juan Marqués-Lespier; José Muñoz-Acabá; Rafael Pastrana; Cynthia M Pérez-Cardona; Yasuhiro Yamamura; Esther A Torres
Journal:  P R Health Sci J       Date:  2014-12       Impact factor: 0.705

2.  Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.

Authors:  Brad R Rosenberg; Catherine A Freije; Naoko Imanaka; Spencer T Chen; Jennifer L Eitson; Rachel Caron; Skyler A Uhl; Marija Zeremski; Andrew Talal; Ira M Jacobson; Charles M Rice; John W Schoggins
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

3.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

4.  Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.

Authors:  Peter V Aka; Mark H Kuniholm; Ruth M Pfeiffer; Alan S Wang; Wei Tang; Sabrina Chen; Jacquie Astemborski; Michael Plankey; Maria C Villacres; Marion G Peters; Seema Desai; Eric C Seaberg; Brian R Edlin; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson; Gerald B Sharp; Thomas R O'Brien
Journal:  J Infect Dis       Date:  2013-08-15       Impact factor: 5.226

5.  Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

Authors:  Moutaz Derbala; Nasser Rizk; Fatima Shebl; Saad Alkaabi; Nazeeh Eldweik; Anil John; Manik Sharma; Rafie Yaqoob; Muneera Almohanadi; Mohammed Butt; Khaled Alejji
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.

Authors:  Lorenzo Uccellini; Fan-Chen Tseng; Alessandro Monaco; Fatma M Shebl; Ruth Pfeiffer; Myhanh Dotrang; Dianna Buckett; Michael P Busch; Ena Wang; Brian R Edlin; Francesco M Marincola; Thomas R O'Brien
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425

7.  Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.

Authors:  Hamid Heidarian Miri; Pooria Fazeli; Mohammad Ali-Hassanzadeh; Peyman Bemani; Dieter Kabelitz; Kurosh Kalantar
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

Review 8.  The Genetic Association of IFN-λs with Human Inflammatory Disorders Remains a Conundrum.

Authors:  Sreedhar Chinnaswamy; Marek L Kowalski
Journal:  J Interferon Cytokine Res       Date:  2019-06-04       Impact factor: 2.607

9.  Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.

Authors:  Sayeh Ezzikouri; Rhimou Alaoui; Khadija Rebbani; Ikram Brahim; Fatima-Zohra Fakhir; Salwa Nadir; Helmut Diepolder; Salim I Khakoo; Mark Thursz; Soumaya Benjelloun
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati.

Authors:  G L Abby Harrison; Jan Pryor; Joji Malani; Mathias Supuri; Andrew Masta; Burentau Teriboriki; Tebuka Toatu; David Penny; Jean-Pierre Allain; Eleanor Barnes; Oliver G Pybus; Paul Klenerman
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.